mushroom

Riffyn Doubles Customers and Recurring Revenue for Fourth Straight Year

Software

Home » Emerging technologies » Software

mushroom

Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic

The leading life sciences R&D cloud added 150 customers, including biotech innovators Gilead Sciences, Sanofi, and UCB SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ — With biotech seizing headlines amid the COVID...

mushroom

LanzaTech and TeselaGen Biotechnology Sign New Multi-Year Deal to Advance Carbon Remediation via Biological Processes

Riffyn Selected as the Digital Backbone of BioMADE Network to Advance Domestic Biomanufacturing Innovation

Riffyn was selected as a key digital-infrastructure partner of BioMADE — the $87.5M DoD-sponsored biomanufacturing network — to future-proof America’s biomanufacturing economy. December 01, 2020 12:05 PM Eastern...

mushroom

Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development Through Automation

mushroom

Synthace Announces the Launch of New Product Helping Scientists Execute and Scale Key Assays

mushroom

Machine Learning and Synthetic Biology used to Optimize a Cellular Factory for Industrially Relevant Products

TdT

Ansa Biotechnologies partners with TeselaGen Biotechnology to enable commercial production of DNA products

virus

You’ve Heard Of Computer-Aided Design. What About Computer-Aided Biology?

mushroom

SynBioBeta Podcast! Hosted Live and exclusively for our Bioeconomy Hub Members.

mushroom

New Cyrus Biotechnology Antibody Structure Prediction Software “NextGen” Outperforms Schrödinger and Other Software in Third-Party Test

Computer-aided biology

Computer-Aided Biology: The Metadata Responsibility

mushroom

From WTF to WFH: Building a digital backbone for faster, cheaper, better science in a decentralized world

Synthetic biology and America’s future: New opportunities for working with the U.S. government

mushroom

From WTF to WFH: Building a digital backbone for faster, cheaper, better science in a decentralized world

mushroom

ATUM Provides COVID-19 Diagnostic and Therapeutic Developers Free Access to its Protein Synthesis Platform